A Study to Further Assess Safety and Effectiveness Data of the Bortezomib(Velcade)/Melphalan/Prednisone (BMP) Regimen in Previously Untreated and Transplant Ineligible Multiple Myeloma Patients

This study has been terminated.

( Slower than anticipated recruitment and stopping criteria defined in protocol resulted in early termination of study. )

Study NCT00799539 Information provided by Janssen-Ortho Inc., Canada

First Received: November 26, 2008 Last Updated: August 12, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	June 2009
Primary Completion Date:	June 2009 (Final data collection date for primary outcome measure)